Patent · US Expired

"1-(2'-Aroyl eth-1'yl) 2-(4""-acetamido piperazine-1""yl methyl) benzimidazoles and their therapeutical applications"

US4104384A · kind A · utility

0Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 1977
Grant dateAug 1, 1978
Priority date
Expiry dateNov 28, 1997

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D235/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the formula ##STR1## where Ar is phenyl, substituted phenyl, .alpha.-furyl or .alpha.-thienyl, and PA1 R is NH.sub.2, NHR.sup.1 wherein R.sup.1 is alkyl or cycloalkyl, or NR.sub.1 R.sub.2 wherein PA1 R.sub.1 and R.sub.2 are alkyl or --N.sub.1 R.sub.1 R.sub.2 is piperidino, pyrrolidino, morpholino or hexamethyleneimino. The compounds are prepared by reacting the corresponding Ar-substituted chloromethylated benzimadazole with the corresponding R-substituted piperazine. The compounds possess gastric antisecretory, anti-ulcerous, spasmolytic, anti-cholinergic, anti-bronchoconstrictive, analgesic, anti-inflammatory, anti-hypertensive and diuretic properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.